From Bio Co

From Bio Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of From Bio Co (377220.KQ) as of Oct 16, 2026 is -29.87 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -29.59 % — a change of 0.93% (lower).

EBIT/Assets

-29.87 %

YoY

0.93%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of From Bio Co is 2025 -29.87 % . Operating Income to Assets Ratio (EBIT/Assets) of From Bio Co was 2024 -29.59 % . It decreases by 0.93% lower compared to the previous year.

The From Bio Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
20.84 KRW
Jan 1, 2020
44.33 KRW
Jan 1, 2021
11.76 KRW
Jan 1, 2022
0.85 KRW
Jan 1, 2023
-15.94 KRW
Jan 1, 2024
-29.59 KRW
Jan 1, 2025
-29.87 KRW
The From Bio Co EBIT/Assets history
YEAREBIT/AssetsYoY
-29.87 %+0.93%
-29.59 %+85.69%
-15.94 %-1,975.24%
0.85 %-92.78%
11.76 %-73.46%
44.33 %+112.66%
20.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

From Bio Co Stock analysis

What does From Bio Co do? From Bio Co Ltd, listed on the Korea Exchange under ticker 377220.KQ with ISIN KR7377220009, is a South Korean company based in Yongin. The company operates within the Consumer Staples sector, specifically in the Food Products industry. It went public through an IPO on September 28, 2021. From Bio Co Ltd employs 123 people. The company is involved in the manufacture and sale of health functional food products. Its product range includes items related to joint health, stomach health, eye health, and sleep health. Additionally, the company produces and sells wild mango and other diet foods, as well as creams, shampoos, and soaps. The company's website is https://www.frombio.co.kr/. The headquarters is located in Yongin, Gyeonggi-Do, South Korea. The company's activities focus on consumer health and wellness products, with a diverse portfolio spanning multiple health categories and personal care items. From Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about From Bio Co stock

Operating Income to Assets Ratio (EBIT/Assets) of From Bio Co is -29.87 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of From Bio Co changed from -29.59 % to -29.87 %, representing a 0.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) From Bio Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s From Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — From Bio Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — From Bio Co